Impact of Lodos Aspirin on Iron Deficiency and Anemia in Elderly: Study Analysis

A study analyzed the impact of Lodos Aspirin on iron deficiency and anemia in elderly individuals. The study was part of the Aspirin in Reducing Events in the Elderly trial, which evaluated the effects of aspirin in healthy older individuals for primary prevention. The trial showed that while aspirin did not prolong disability-free survival, it increased the risk of major bleeding. As part of the trial, participants had regular hemoglobin measurements, allowing researchers to assess the development of anemia. The study found that the risk of developing anemia over five years was higher in the aspirin group compared to the placebo group. Additionally, participants receiving aspirin had a steeper decline in hemoglobin levels compared to those on placebo.